Psychogenic @entity1643 and XXXX in Adolescence.

@entity1 @entity1643 @entity11167 @entity146 @entity425 @entity5539 @entity4490 @entity158 @entity912 @entity347
STUDY DESIGN: A retrospective review. OBJECTIVE: The purpose of this study was to investigate the clinical outcomes in adolescents diagnosed with @entity1643 and @entity912 and to evaluate the efficacy of differential diagnosis methods. SUMMARY OF BACKGROUND DATA: The incidence of @entity1643 in adolescence is similar to that in adults, but the causes of @entity1643 are difficult to determine in most cases. For these @entity1 , a definitive diagnosis of @entity1643 and @entity912 as well as adequate treatment are clinically important to avoid unnecessary surgical treatment. METHODS: Eleven @entity1 [3 males and 8 females; mean age, 16.5 years (range, 13-19 y)] diagnosed with @entity1643 and @entity912 were followed up for 2-10.25 years (mean, 4.67 y). Nonorganic signs were observed in almost all @entity1 . For the purpose of excluding @entity347 , the @entity4490 @entity158 study was used in @entity1 who complained mainly of @entity158 , and motor evoked potentials (MEPs) using transcranial magnetic stimulation were measured in @entity1 experiencing primarily @entity425 . RESULTS: The @entity146 diagnosis was @entity11167 in 9 @entity1 , whereas it was @entity5539 in 2 @entity1 . Conservative treatment, such as physiotherapy, was performed, and at the final follow-up evaluation, outcomes were regarded as excellent in 7 @entity1 and good in 4 @entity1 . CONCLUSIONS: The prognosis of @entity1643 and @entity912 in adolescence is relatively good. However, it is important to understand the characteristics of @entity1643 and @entity912 in childhood and young adulthood and to perform accurate diagnosis via screening for nonorganic signs and excluding @entity347 by using the @entity4490 @entity158 study and MEPs obtained using transcranial magnetic stimulation.
